←
Fever Dream112 posts
Fever Dream avatar

Fever Dream

@fdreamfacts

if you're not educating patients online, misinformation will do it for you 🫀

◷ Joined June 2016
Stefan Kertesz, MD, MSc avatar
⟳ Fever Dream retweeted
Stefan Kertesz, MD, MSc@StefanKertesz·22h

The clinical evaluations that teaching docs fill out on med students and residents have poor validity and almost no predictive value. Why fill them out at all? It is, my cohost suggests, "the tail wagging the dog" We work in a system that wants to rank people, even though it doesn't want to invest seriously in high-quality evaluation. Teaching doctors work in a system where blue-ribbon commissions create impressive "clinical milestones" for us to box-check in a few minutes between emails, after we've been nagged enough to do so. Ranking systems, even fallacious ones, allow residency programs and fellowships to say "we took the best of the best!" But the behemoth of "ranking, no matter how invalid" is not the best use of our medical educational talent. Learn more at "On Becoming a Healer" pod.link/healer/episode/ZjI3…

4:16
AACR avatar
⟳ Fever Dream retweeted
AACR@AACR·12h

The AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant is a 3-year, $300,000 grant to support independent investigators conducting research on monosomy 7 AML and/or other high-risk cytogenetic AML subtypes. Apply by Dec 1: brnw.ch/21x7awA

Post attachment
Professor Georgina Long AO (Bluesky @gvlongphdmd) avatar
⟳ Fever Dream retweeted
Professor Georgina Long AO (Bluesky @gvlongphdmd)@ProfGLongMIA·Nov 17

Honoured and proud to present the results of INTerpath-001 at ESMO: a randomised controlled phase 3 trial of a #personalised therapeutic cancer vaccine. Individualised neoantigen therapy (intismeran) plus pembrolizumab versus pembrolizumab alone, the current standard of care across the world, in high-risk, early-stage melanoma completely removed by surgery (stage IIB to IIID, and some resected stage IV with no evidence of disease). This is cutting-edge science, and it needs to be understood properly. No hype, no noise.  The real data and what they mean for patients. Watch the presentation: melanoma.org.au/news/interpa… At @MelanomaAus our focus is our patients, and curing those we have not yet cured. The therapies my team and I have developed over the last 15 years cure about half of people with stage IV melanoma and prevent stage IV in many with stage II and III. Not everybody, yet. Our multidisciplinary team meeting is world renowned, with leading clinicians with expertise in melanoma and complex skin cancer from diagnosis, management, drug therapies and clinical trials. We discuss the hardest cases, and the evidence we generate shapes clinical practice guidelines around the world. What happens in melanoma impacts other cancers, and we learn from other cancers. Melanoma IS the immunotherapy cancer. #melanoma #immunotherapy #interpath001 #esmo26 @myESMO @Sydney_Uni @syd_health @Science_Academy @AAHMS_health @FulbrightAUS @NthSydHealth @ausoftheyear

Post attachment
Janice Cowden avatar
⟳ Fever Dream retweeted
Janice Cowden@JaniceTNBCmets·Nov 17

👏 These FDA approvals represent incredible progress, but we can’t overlook the patients who aren’t benefiting. In an MBC FB group I co-facilitate, with nearly 5,000 global members, patients repeatedly ask about options for those w/o ESR1 mutations. We need to accelerate research & expand treatment options for ALL with HR+/HER2- #mbc. #bcsm

Post attachmentPost attachment

The evERA study / giredestrant approval is interesting because the @FDA did not approve the drug for the whole study population. The evERA trial accrued for tumors w/w/o ESR1 mutations. The overall result was positive. But study was designed to focus on ESR1 mutated tumors, and there was no/minimal benefit in ESR1 wildtype cohort. So FDA only granted approval into the already-crowded space of 2nd line ET for ESR1 mutated tumors. Here are data from @NEJM Supplemental appendix for the ESR1 wt subset (below).

Post attachment
Max Jaderberg avatar
⟳ Fever Dream retweeted
Max Jaderberg@maxjaderberg·Nov 17

An amazing moment at Iso as we close our Series C funding round! We founded Iso on the conviction that AI can transform biology into a programmable science. We are clearly seeing this play out internally with our models’ capabilities translating into new potential medicines for patients. This funding will supercharge our efforts, so we can push even deeper into the hard problems of understanding disease biology, engineering the most exquisite molecules possible, and bringing new drugs to patients who need them. Lots more to come!

We’ve closed our $5 Billion funding round co-led by Greenoaks and Sequoia Capital to build the future of medicine and bioengineering with AI. isomorphiclabs.com/articles/…

0:37
Peter Pattison avatar
⟳ Fever Dream retweeted
Peter Pattison@bsc_io_e·Nov 17

100+ physicians gathered this past weekend for our #catalyze2026 Liver Cancer Summit, exchanging perspectives on #hcc, #colorectallivermetastases, & #cholangiocarcinoma. Through multidisciplinary collaboration & evidence-based discussions, attendees explored evolving treatment approaches, including #y90, #haitherapy, & systemic therapies, with a shared focus on improving patient outcomes. Thank you to our faculty & attendees for sharing their expertise & making this event a success! #livercancer

Post attachmentPost attachmentPost attachmentPost attachment
PMNCH avatar
⟳ Fever Dream retweeted
PMNCH@PMNCH·Nov 17

Climate action must protect those most at risk. At #cop31, PMNCH is calling for resilient health systems, sustained essential services and meaningful youth participation to advance women's, children's and adolescents' health. Explore our key messages: pmnch.who.int/docs/libraries…

Post attachmentPost attachmentPost attachmentPost attachment
Israel Fernandez avatar
⟳ Fever Dream retweeted
Israel Fernandez@IsraelF96135088·Nov 17

Picking, the most underrated step in cryoEM structure determination. Spend some time picking your data properly. @alexjamesnoble is right here!

In cryoEM processing, everything is downstream from particle picking. We re-picked a public 49 kDa membrane protein dataset (PfCRT + Fab) with Topaz: 5× more particles in the final map, 3.3 Å published → 2.9 Å, no new microscope time. Rarest views: 9.4× cryoarcana.com/case-studies/…

0:36
Dr. Adil Shamji 🇨🇦 avatar
⟳ Fever Dream retweeted
Dr. Adil Shamji 🇨🇦@ShamjiAdil·Nov 17

Every day, health care workers in Ontario are asked to do more with less. Too many of them are underpaid, underappreciated, and placed in precarious or dangerous situations. The Health Care HEROES Act changes that. It is the first strategy, in recent history, focused on improving morale, retention, and workplace satisfaction. If we want a strong health care system, we need a strong health care workforce - because the conditions of work are the conditions of care.

1:42
Neena Jha avatar
⟳ Fever Dream retweeted
Neena Jha@DrNeenaJha·Nov 17

The whole concept of an ACP role is misleading. How can almost every HCP: physio, OT, pharmacist, nurse, PA- ALL do the SAME course & work in the same role?! By definition that cannot be advanced practice in a base profession It’s doctor replacement without a medical degree

BIDMC CVD Fellowship avatar
⟳ Fever Dream retweeted
BIDMC CVD Fellowship@BIDMCVFellows·Nov 16

They roasted our faculty (with love) at the annual fellows' skit night. Then they went on to win NIH grants, advanced specialty training, and amazing faculty positions. Proud of our recent fellowship grads🫀@ChristinaLalani @margot_y

Post attachment
Harold J. Burstein, MD, PhD, FASCO avatar
⟳ Fever Dream retweeted
Harold J. Burstein, MD, PhD, FASCO@DrHBurstein·Nov 17

The evERA study / giredestrant approval is interesting because the @FDA did not approve the drug for the whole study population. The evERA trial accrued for tumors w/w/o ESR1 mutations. The overall result was positive. But study was designed to focus on ESR1 mutated tumors, and there was no/minimal benefit in ESR1 wildtype cohort. So FDA only granted approval into the already-crowded space of 2nd line ET for ESR1 mutated tumors. Here are data from @NEJM Supplemental appendix for the ESR1 wt subset (below).

Post attachment

📣 Today #fda approved giredestrant in combination with everolimus for adults with ER+/HER-/ESR1 mutated #metastaticbreastcancer after prior endocrine therapy in adjuvant or advanced setting. More detailed info here: fda.gov/drugs/cancer-approva…. #onctwitter #bcsm #medtwitter

Post attachment
Yara Abdou, MD, MSCR avatar
⟳ Fever Dream retweeted
Yara Abdou, MD, MSCR@YAbdouMD·Nov 16

Can ctDNA help us detect molecular residual disease and guide personalized treatment in patients with high-risk TNBC? Our @TheTBCRC PREDICT-RD trial is investigating MRD-guided treatment with datopotamab deruxtecan (Dato-DXd) in patients with persistent ctDNA after neoadjuvant therapy and surgery. Now open at @UNC_Lineberger and @ONealCancerUAB Opening soon at @UChicago, @MontefioreNYC @MayoCancerCare & @DukeCancer Thank you @PRIMR_MED for highlighting our study and helping raise awareness! 🎥 Watch below! #bcsm

New video! 📢 The PREDICT-RD trial studies whether MRD testing can catch early #breastcancer recurrence and guide personalized treatment for patients who still have TNBC remaining after surgery. Watch: primrmed.com/cancer-clinical… @NateraGenetics @YAbdouMD @UNC_Lineberger

0:33
Dr Amol Akhade avatar
⟳ Fever Dream retweeted
Dr Amol Akhade@SuyogCancer·Nov 16

Oncowisdom is happy to invite you all for this academic webinar on key trials from esmo 26. 20 th November 7.30 pm IST If u missed the Q& A sessions at esmo26 , do join us to dive deep. @Timothee_MD Dr Saeed Rafii @DrUddiGoswami Dr T P Sahoo . Scan to register 🙂 👇

Post attachment